1‐{1‐[(2‐Chlorothiazol‐5‐yl)methyl]‐2‐[(2‐chlorothiazol‐5‐yl)methylsulfanyl]‐4‐methyl‐6‐phenyl‐1,6‐dihydropyrimidin‐5‐yl}ethanone

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|63|8|o3516-o3516

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.63, Iss.8, 2007-08, pp. : o3516-o3516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1‐{6‐(4‐Chlorophenyl)‐1‐[(6‐chloropyridin‐3‐yl)methyl]‐2‐[(6‐chloropyridin‐3‐yl)methylsulfanyl]‐4‐methyl‐1,6‐dihydropyrimidin‐5‐yl}ethanone

By  

Acta Crystallographica Section E, Vol. 63, Iss. 5, 2007-05 ,pp. : o2506-o2507

John Wiley & Sons Inc

Access to resources Recommend Favorite

(2‐Chlorothiazol‐5‐yl)methyl 4‐nitrophenyl carbonate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4624-o4624

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐[1‐(2‐Hydroxyethyl)‐6‐methyl‐2‐phenyl‐4‐thioxo‐1,4‐dihydropyrimidin‐5‐yl]‐1‐ethanone

By  

Acta Crystallographica Section E, Vol. 63, Iss. 6, 2007-06 ,pp. : o2850-o2850

John Wiley & Sons Inc

Access to resources Recommend Favorite

O,O‐Diethyl [({1‐[(2‐chloro­thia­zol‐5‐yl)meth­yl]‐5‐methyl‐1H‐1,2,3‐triazol‐4‐yl}carbon­yloxy)phenyl­meth­yl]phospho­nate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 1, 2007-01 ,pp. : o158-o160

John Wiley & Sons Inc

Access to resources Recommend Favorite

3‐[(2‐Chlorothiazol‐5‐yl)methyl]‐5‐(isobutylamino)‐6‐phenyl‐3H‐1,2,3‐triazolo[4,5‐d]pyrimidin‐7(6H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 6, 2007-06 ,pp. : o2843-o2843

John Wiley & Sons Inc

Access to resources Recommend Favorite